KILL Sensyne Health and OMNY Health Sign Teaming Agreement to Support Breakthrough Research Through the Power of Real World Data and AI
15 Octubre 2021 - 6:14PM
Business Wire
Sensyne Health requests that their press release NewsItemId:
20211015005121 “Sensyne Health and OMNY Health Sign Teaming
Agreement to Support Breakthrough Research Through the Power of
Real World Data and AI” be killed.
The release was issued in error by Sensyne Health. A replacement
release will not be issued.
Sensyne Health (www.sensynehealth.com) +44 (0) 330 058
1845 Lord (Paul) Drayson PhD FREng, Chief Executive Officer Dr
Richard Pye, Chief Financial Officer
Peel Hunt LLP (Nominated Adviser and Joint Broker) +
44 (0) 20 7418 8900 Dr Christopher Golden James Steel Victoria
Erskine
Liberum (Joint Broker) + 44 (0) 20 3100 2000 Bidhi
Bhoma Euan Brown
Consilium Strategic Communications +44 (0) 77 0286
8207 Mary-Jane Elliott Jessica Hodgson
CSCSensynehealth@consilium-comms.com
Sensyne Health (LSE:SENS)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Sensyne Health (LSE:SENS)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024
Real-Time news about Sensyne Health Plc (London Stock Exchange): 0 recent articles
Más de Sensyne Health. Artículos de Noticias